Autopsy report · NCT01538901

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients

“prolonged recruitment phase”

The sponsor’s own words in the registry.

Life of this trial

• Registered 7 months before it started.
• Ran for about 2 years before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Medical University of Vienna

Sponsor type

University, hospital or other

Conditions

Actinic Keratoses

Interventions

photodynamic therapy; imiquimod 5% cream

Participants

10

Sites

2

Countries

Austria

Trials that died the same way

• A Multicenter Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months
  “end of recruitment” (82% match in meaning)
• Physical Activity as an Aid for Smoking Cessation
  “End of the recruitment” (80% match in meaning)
• Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department
  “Slow pace of recruitment” (79% match in meaning)
• Iloprost for Bridging to Heart Transplantation in PH
  “Delay in recruitment” (79% match in meaning)
• Role of the NLRP3 Inflammasome in Escherichia Coli and Staphylococcus Aureus Bacteria
  “End of recruitment period” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.